Eplontersen sodium structure
|
Common Name | Eplontersen sodium | ||
|---|---|---|---|---|
| CAS Number | 2131025-75-5 | Molecular Weight | 9046.10 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C296H417N77Na20O156P20S13 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Eplontersen sodiumEplontersen sodium is a triantennary N-acetyl galactosamine (GalNAc3-7a)-conjugated antisense oligonucleotide targeting transthyretin (TTR) mRNA to inhibit production of both variant and wild-type TTR protein. Misfolded TTR induces amyloid fibrils formation in the heart and peripheral nerves, leads to amyloid TTR (ATTR) amyloidosis diseases[1][2][3]. |
| Name | Eplontersen sodium |
|---|
| Description | Eplontersen sodium is a triantennary N-acetyl galactosamine (GalNAc3-7a)-conjugated antisense oligonucleotide targeting transthyretin (TTR) mRNA to inhibit production of both variant and wild-type TTR protein. Misfolded TTR induces amyloid fibrils formation in the heart and peripheral nerves, leads to amyloid TTR (ATTR) amyloidosis diseases[1][2][3]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C296H417N77Na20O156P20S13 |
|---|---|
| Molecular Weight | 9046.10 |